Cargando…
MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value
BACKGROUND: The microRNA miR-221-3p has previously been found to be an underlying biomarker of pancreatic cancer. However, the mechanisms of miR-221-3p underlying its role in pancreatic cancer pathogenesis, proliferation capability, invasion ability, drug resistance and apoptosis and the clinicopath...
Autores principales: | Wu, Xuejiao, Huang, Jia, Yang, Zilin, Zhu, Ying, Zhang, Yongping, Wang, Jiancheng, Yao, Weiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488115/ https://www.ncbi.nlm.nih.gov/pubmed/32943991 http://dx.doi.org/10.1186/s12935-020-01529-9 |
Ejemplares similares
-
Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues
por: Liu, Yongru, et al.
Publicado: (2015) -
Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer
por: Ge, Jie, et al.
Publicado: (2014) -
Bioinformatics identification of potentially involved microRNAs in Tibetan with gastric cancer based on microRNA profiling
por: Luo, Yushuang, et al.
Publicado: (2015) -
MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker
por: Goto, Yusuke, et al.
Publicado: (2015) -
MicroRNA-492 expression promotes the progression of hepatic cancer by targeting PTEN
por: Jiang, Jianxin, et al.
Publicado: (2014)